Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece
- PMID: 32871850
- PMCID: PMC7652506
- DOI: 10.21873/invivo.12138
Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece
Abstract
Background: Antibody testing is necessary to identify immune individuals in the post-initial wave of the COVID-19 pandemic.
Patients and methods: We prospectively evaluated the performance of a quantitative point-of-care test (POCT) for SARS-CoV-2 antibodies. The patient group (PG) comprised of hospitalized confirmed COVID-19 cases. Asymptomatic healthcare volunteers with negative rRT-PCR were included in the control group (CG). Measurement of IgM and IgG was obtained by dry fluorescence immunoassay.
Results: Twenty-six PG (65.9±15.4 years old, male 57.7%) and 18 CG (45.6±10.1 years old, male 33.3%) were included. By manufacturer's cut-off (≥0.04 mIU/ml), sensitivity and specificity were 73.08% and 88.89% for IgM and 88.46% and 33.33% for IgG, respectively. Estimated areas under the ROC curve were 0.907 and 0.848 for IgM and IgG, respectively. Results were improved using a cut-off of IgM ≥0.05 mIU/ml and IgG ≥0.10 mIU/ml.
Conclusion: Using stringent cut-off values, SARS-CoV-2 antibody POCT detects immune people and can be used during socioeconomic normalization of communities.
Keywords: COVID-19; IgG; IgM; SARS-CoV-2; antibodies; diagnostics; novel coronavirus; point-of-care testing.
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
The Authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Consumables, test strips and the reader were provided for free by Lansion Biotech.
Figures


References
-
- COVID-19 situation reports. The World Health Organization. Available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation... [Last accessed on 01 June 2020]
-
- Strategic preparedness and response plan for the novel coronavirus. The World Health Organization. Available at: https:// www.who.int/publications-detail/strategic-preparedness-andresponse-plan-... [Last accessed on 01 June 2020]
-
- Infection prevention and control. The World Health Organization. Available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/technical... [Last accessed on 01 June 2020]
-
- COVID-19. European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/en/covid-19-pandemic [Last accessed on 01 June 2020] - PubMed
-
- Li D, Wang D, Dong J, Wang N, Huang H, Xu H, Xia C. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: Role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21(4):505–508. doi: 10.3348/kjr.2020.0146. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous